Published :
Tables : 54
Figures : 47
Category : Healthcare
No. of Pages : 235
Report Code : HC-U4719
Europe In-Vitro Diagnostics Market is estimated to register a CAGR of over 5.5% during the forecast period 2020 to 2027. FutureWise Market Research has instantiated a report that provides an intricate analysis of Europe In-Vitro Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Europe In-Vitro Diagnostics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Europe In-Vitro Diagnostics Market: • Abbott Laboratories • Becton, Dickinson and Company • Bio-Rad Laboratories Inc. • Danaher Corporation (Beckman Coulter, Inc) • Johnson & Johnson • Roche Diagnostics • Siemens Healthcare • Thermo Fisher Scientific Inc. • Sysmex Corporation • QIAGEN • BioMerieux SA • Tesa SE • Cepheid, Inc. • Hologic, Inc. (Gen Probe) • OraSure Technologies • Alere, Inc. • Quidel Corporation (Note: The list of the major players will be updated with the latest market scenario and trends) Europe In-Vitro Diagnostics Market Segmentation: By Test Type • Clinical Chemistry • Molecular Diagnostics • Hematology • Immuno Diagnostics • Other Test Types By Product • Instrument • Reagents • Other Products By Usability • Disposable IVD Devices • Reusable IVD Devices By Application • Infectious Disease • Diabetes • Cancer/Oncology • Cardiology • Autoimmune Disease • Nephrology • Other Applications By End User • Diagnostic Laboratories • Hospitals and Clinics • Other End Users By Region • Germany • U.K • Italy • Spain • Russia • Poland • Rest of Europe Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Europe In-Vitro Diagnostics Market By Test Type, By Product, By Usability, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— Germany, U.K, Italy, Spain, Russia, Poland, Rest of Europe • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Europe In-Vitro Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Europe In-Vitro Diagnostics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Europe In-Vitro Diagnostics Market: • Abbott Laboratories • Becton, Dickinson and Company • Bio-Rad Laboratories Inc. • Danaher Corporation (Beckman Coulter, Inc) • Johnson & Johnson • Roche Diagnostics • Siemens Healthcare • Thermo Fisher Scientific Inc. • Sysmex Corporation • QIAGEN • BioMerieux SA • Tesa SE • Cepheid, Inc. • Hologic, Inc. (Gen Probe) • OraSure Technologies • Alere, Inc. • Quidel Corporation (Note: The list of the major players will be updated with the latest market scenario and trends) Europe In-Vitro Diagnostics Market Segmentation:
By Test Type • Clinical Chemistry • Molecular Diagnostics • Hematology • Immuno Diagnostics • Other Test Types By Product • Instrument • Reagents • Other Products By Usability • Disposable IVD Devices • Reusable IVD Devices By Application • Infectious Disease • Diabetes • Cancer/Oncology • Cardiology • Autoimmune Disease • Nephrology • Other Applications By End User • Diagnostic Laboratories • Hospitals and Clinics • Other End Users By Region • Germany • U.K • Italy • Spain • Russia • Poland • Rest of Europe Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Europe In-Vitro Diagnostics Market By Test Type, By Product, By Usability, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— Germany, U.K, Italy, Spain, Russia, Poland, Rest of Europe • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Europe In-Vitro Diagnostics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Europe In-Vitro Diagnostics Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Europe In-Vitro Diagnostics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Europe In-Vitro Diagnostics Market, By Test Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Clinical Chemistry 7.2. Molecular Diagnostics 7.3. Hematology 7.4. Immuno Diagnostics 7.5. Other Test Types 8. Europe In-Vitro Diagnostics Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Instrument 8.2. Reagents 8.3. Other Products 9. Europe In-Vitro Diagnostics Market, by Usability Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Disposable IVD Devices 9.2. Reusable IVD Devices 10. Europe In-Vitro Diagnostics Market, by Application Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Infectious Disease 10.2. Diabetes 10.3. Cancer/Oncology 10.4. Cardiology 10.5. Autoimmune Disease 10.6. Nephrology 10.7. Other Applications 11. Europe In-Vitro Diagnostics Market, by End User Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Diagnostic Laboratories 11.2. Hospitals and Clinics 11.3. Other End Users 12. Europe Europe In-Vitro Diagnostics Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Market Share Analysis and Competitive Landscape 13.1. Europe Landscape - Key Players, Revenue and Presence 13.2. Europe Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 13.3. Europe Emerging Companies 13.4. Europe - Market Share Analysis and Key Regional Players 13.5. Europe Key Player - Growth Matrix 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 14.1. Abbott Laboratories 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Becton, Dickinson and Company 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Bio-Rad Laboratories Inc. 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Danaher Corporation (Beckman Coulter, Inc) 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Johnson & Johnson 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. Roche Diagnostics 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Siemens Healthcare 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Thermo Fisher Scientific Inc. 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. Sysmex Corporation 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10.QIAGEN 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11.BioMerieux SA 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 14.12.Tesa SE 14.12.1. Company Overview 14.12.2. Product Portfolio 14.12.3. SWOT Analysis 14.12.4. Financial Overview 14.12.5. Strategic Overview 14.13.Cepheid, Inc. 14.13.1. Company Overview 14.13.2. Product Portfolio 14.13.3. SWOT Analysis 14.13.4. Financial Overview 14.13.5. Strategic Overview 14.14.Hologic, Inc. (Gen Probe) 14.14.1. Company Overview 14.14.2. Product Portfolio 14.14.3. SWOT Analysis 14.14.4. Financial Overview 14.14.5. Strategic Overview 14.15. OraSure Technologies 14.15.1. Company Overview 14.15.2. Product Portfolio 14.15.3. SWOT Analysis 14.15.4. Financial Overview 14.15.5. Strategic Overview 14.16.Alere, Inc. 14.16.1. Company Overview 14.16.2. Product Portfolio 14.16.3. SWOT Analysis 14.16.4. Financial Overview 14.16.5. Strategic Overview 14.17.Quidel Corporation 14.17.1. Company Overview 14.17.2. Product Portfolio 14.17.3. SWOT Analysis 14.17.4. Financial Overview 14.17.5. Strategic Overview 15. Pre and Post COVID-159 Impact 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics